ArticleInternational journal of molecular sciences2026
Evaluation of AlphaFold3 for Predicting Human Heme-Binding Protein Structures.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Heme is a crucial cofactor involved in various biological processes, such as electron transport, catalysis, and oxygen binding. Understanding the binding of heme to heme-binding proteins (HBPs) is essential for clarifying their functions and molecular mechanisms and for applications in enzyme engineering and therapeutic development. AlphaFold3 (AF3), an artificial intelligence (AI)-based macromolecular prediction tool, has been applied to the structural modeling of various proteins, including HBPs. Nevertheless, whether AF3 provides reliable structural information for HBPs has not yet been investigated. To determine the AF3 predictions for HBPs, the apo and holo states of four human HBPs, including the cytochrome b5 domain of sulfite oxidase (SO-b5), the cytochrome b5 domain of NADH cytochrome b5 oxidoreductase (Ncb5or-b5), cytochrome b5 type B (CYB5B), and neuroglobin (NGB), generated by AF3, were examined and compared with experimental HBP structures. The overall positions of the heme molecules were well docked into the heme-binding pockets of HBPs; however, there were differences in the heme-binding configurations, including pocket geometry and coordination environment, which are crucial for functional interpretation. The experimental NGB structure contains a disulfide bond near the heme-binding region, whereas the AF3-predicted model lacks this bond, causing differences in local folding that affect the heme-binding environment. Molecular dynamics simulations demonstrated that the AF3-predicted NGB structure exhibited distinct molecular conformations and flexibility compared with the experimental structure. These data indicate both the potential and the limitations of using AF3-predicted structures to model the heme-binding states of HBPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.